Role of Hydrogen in Atherosclerotic Disease: From Bench to Bedside

Shucun Qin1

  • 1The Institute of Atherosclerosis and Taishan Institute for Hydrogen Biomedicine, Shandong First Medical University and Shandong Academy of Medical Sciences, Taian 271000, China.

Insights

Hydrogen may help prevent and treat atherosclerosis, a major cause of heart and brain disease. Research shows its antioxidant and anti-inflammatory properties are key to its anti-atherosclerotic effects in studies.

Area of Science:

  • Biomedical Science
  • Cardiovascular Research
  • Molecular Medicine

Background:

  • Atherosclerosis (AS) is a leading global cause of death.
  • Cardiovascular and cerebrovascular diseases are major health concerns.
  • Hydrogen is recognized for its antioxidant and anti-inflammatory properties.

Purpose of the Study:

  • To review the role of hydrogen in preventing and treating atherosclerosis.
  • To summarize pathophysiological characteristics and risk factors of AS.
  • To analyze laboratory and human study data on hydrogen's anti-atherosclerotic effects.

Main Methods:

  • Literature review of over 50 English-language publications.
  • Analysis of animal models and human studies on hydrogen and AS.
  • Examination of molecular mechanisms of hydrogen's efficacy.

Main Results:

  • Evidence suggests hydrogen possesses anti-atherosclerotic properties.
  • Studies in animal models and humans indicate potential benefits.
  • Molecular mechanisms underlying hydrogen's efficacy are being explored.

Conclusions:

  • Hydrogen shows promise as a therapeutic agent for atherosclerosis.
  • Further research, including larger clinical trials, is warranted.
  • Deeper investigation into molecular mechanisms is needed for optimal treatment strategies.

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
197
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
503
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
691
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
217
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
261
Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
174